EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects

Jwharah M Al Jadani, Nawal A Albadr, Ghedeir M Alshammari iD, Soheir A Almasri, Farah Fayez Alfayez, Mohammed Abdo Yahya iD

Nutrients · 2023

DOI: 10.3390/nu15224755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Jwharah M Al Jadani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Solanum lycopersicum. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examined the preventative effects of esculeogenin A (ESGA), a newly discovered glycan from tomato, on liver damage and hepatic steatosis in high-fat-diet (HFD)-fed male rats. The animals were divided into six groups (each of eight rats): a control group fed a normal diet, control + ESGA (200 mg/kg), HFD, and HFD + ESAG in 3 doses (50, 100, and 200 mg/kg). Feeding and treatments were conducted for 12 weeks. Treatment with ESGA did not affect gains in the body or fat weight nor increases in fasting glucose, insulin, and HOMA-IR or serum levels of free fatty acids (FFAs), tumor-necrosis factor-α, and interleukin-6 (IL-6). On the contrary, it significantly reduced the serum levels of gamma-glutamyl transpeptidase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total triglycerides (TGs), cholesterol (CHOL), and low-density lipoprotein cholesterol (LDL-c) in the HFD-fed rats. In addition, it improved the liver structure, attenuating the increase in fat vacuoles; reduced levels of TGs and CHOL, and the mRNA levels of SREBP1 and acetyl CoA carboxylase (ACC); and upregulated the mRNA levels of proliferator-activated receptor α (PPARα) and carnitine palmitoyltransferase I (CPT I) in HFD-fed rats. These effects were concomitant with increases in the mRNA, cytoplasmic, and nuclear levels of nuclear factor erythroid 2-related factor 2 (Nrf2), glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), and heme oxygenase-1 (HO); a reduction in the nuclear activity of nuclear factor-kappa beta (NF-κB); and inhibition of the activity of nuclear factor kappa B kinase subunit beta (IKKβ). All of these effects were dose-dependent effects in which a normal liver structure and normal levels of all measured parameters were seen in HFD + ESGA (200 mg/kg)-treated rats. In conclusion, ESGA prevents NAFLD in HFD-fed rats by attenuating hyperlipidemia, hepatic steatosis, oxidative stress, and inflammation by acting locally on Nrf2, NF-κB, SREBP1, and PPARα transcription factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseSolanum lycopersicumRatsMaleAnimalsAntioxidantsPPAR alphaNF-E2-Related Factor 2NF-kappa BLiverDiet, High-FatTriglyceridesAnti-Inflammatory AgentsCholesterolRNA, MessengerSapogenins

Stichwörter der Autor:innen

esculeogenin Ahigh-fat dietinflammationnonalcoholic fatty liver diseaseobesityoxidative stresssteatosis

Substanzen

AntioxidantsPPAR alphaNF-E2-Related Factor 2NF-kappa BTriglyceridesAnti-Inflammatory AgentsCholesterolRNA, Messengerisoesculeogenin ASapogenins

Autor:innen und Institutionen

  • Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Medicine and Surgery, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.

ORCID-Profile: Ghedeir M Alshammari, Mohammed Abdo Yahya

Förderung

  • Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Al Jadani, J. M., Albadr, N. A., Alshammari, G. M., Almasri, S. A., Alfayez, F. F., & Yahya, M. A. (2023). Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects. Nutrients. https://doi.org/10.3390/nu15224755

Vancouver

Al Jadani JM, Albadr NA, Alshammari GM, Almasri SA, Alfayez FF, Yahya MA. Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects. Nutrients. 2023. doi:10.3390/nu15224755

BibTeX
@article{AlJadani2023,
  author = {Al Jadani, Jwharah M and Albadr, Nawal A and Alshammari, Ghedeir M and Almasri, Soheir A and Alfayez, Farah Fayez and Yahya, Mohammed Abdo},
  title = {Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15224755}
}
Kostenlos starten →